Acute leukaemia

• Science & Technology

Cancer Research UK and AstraZeneca’s new antibody maturation technique yields high-affinity Arginase 2 antibody

Researchers in Cambridge have pioneered the development of an innovative affinity maturation technique to generate high-affinity antibody against Arginase 2. Researchers in Cambridge have pioneered the development of an innovative affinity maturation technique to generate high-affinity antibody against Arginase 2.

3 September 2020

• Health & Medicine

Targeted treatment for leukaemia approved on NHS in England 

The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.   The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.  

16 July 2020

• Health & Medicine

Three new treatment options approved for NHS use in Scotland

The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland

26 March 2020

• Health & Medicine

Leukaemia and head and neck cancer drugs not approved for NHS use in England

Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England. Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.

23 January 2020

• Health & Medicine

NICE U-turn opens up new treatment option for some adults with leukaemia

Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England. Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England.

19 June 2019

• Health & Medicine

Leukaemia drug gets initial ‘no’ for NHS in England

Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England. Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England.

6 March 2019

• Health & Medicine

Double NHS decision for CAR T cell immunotherapy in Scotland

Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer. Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.

13 February 2019

• Health & Medicine

First patient receives CAR T cell therapy on NHS

An 11-year-old boy became the first NHS patient to receive a personalised blood cancer immunotherapy on the NHS. An 11-year-old boy became the first NHS patient to receive a personalised blood cancer immunotherapy on the NHS.

31 January 2019

• Personal Stories

Chelsea legend Gianfranco Zola surprises Blues fan and cancer survivor

Gianfranco Zola gave eighteen-year-old Ed Garside the surprise of his life in a special meeting organised by Stand Up To Cancer’s official partner, Hyundai Moto Gianfranco Zola gave eighteen-year-old Ed Garside the surprise of his life in a special meeting organised by Stand Up To Cancer’s official partner, Hyundai Moto

18 October 2018

• Health & Medicine

NHS England to fund personalised blood cancer immunotherapy

A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today. A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today.

5 September 2018

• Health & Medicine

Personalised cancer vaccine may hold leukaemia at bay for longer

A cancer vaccine personalised to individual patients could reduce the chances of a type of blood cancer from returning, a small US study has found. A cancer vaccine personalised to individual patients could reduce the chances of a type of blood cancer from returning, a small US study has found.

8 December 2016

• Science & Technology

Acute myeloid leukaemia is 11 different diseases

Researchers studying the genetic make-up of an aggressive blood cancer, AML, have discovered that it exists in at least 11 different forms. Researchers studying the genetic make-up of an aggressive blood cancer, AML, have discovered that it exists in at least 11 different forms.

9 June 2016